Liver-specific contrast agents for MRI.
Stark
D D
DD
Department of Radiology, Massachusetts General Hospital, Boston.
Elizondo
G
G
Fretz
C J
CJ
D000085:Acetates / Q000633:toxicity; D000818:Animals; D003287:Contrast Media / Q000633:toxicity; D003911:Dextrans; D004492:Edetic Acid / Q000633:toxicity / Q000031:analogs & derivatives; D005029:Ethylenediamines / Q000633:toxicity; D052203:Ferrosoferric Oxide; D005296:Ferrous Compounds / Q000633:toxicity; D007501:Iron; D008114:Liver Neoplasms, Experimental / Q000175:diagnosis* / Q000556:secondary; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D008536:Meglumine / Q000031:analogs & derivatives*; D009942:Organometallic Compounds / Q000633:toxicity; D010087:Oxides; D011732:Pyridoxal Phosphate / Q000031:analogs & derivatives / Q000633:toxicity; D051381:Rats
D000085:Acetates; D003287:Contrast Media; D003911:Dextrans; D005029:Ethylenediamines; C067088:Fe-HBED; D005296:Ferrous Compounds; D058185:Magnetite Nanoparticles; D009942:Organometallic Compounds; D010087:Oxides; C064572:gadobenic acid; D011732:Pyridoxal Phosphate; D008536:Meglumine; C055242:iron-ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid); D004492:Edetic Acid; D007501:Iron; C065507:ferumoxides; C060076:N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid; D052203:Ferrosoferric Oxide